Literature DB >> 11817382

Informed consent in two Swedish prisons: a study of quality of information and reasons for participating in a clinical trial.

N Lynöe1, M Sandlund, L Jacobsson.   

Abstract

OBJECTIVES: To study the quality of informed consent in two samples of prisoners participating in a therapeutic trial.
RESULTS: All participants (n=43) were aware of the fact that they had participated in a research project, that they were free to abstain from participation, and that they were free to withdraw from participation at any time. All but six were aware of the objective of the clinical trial and all but three understood the implications of participating. Twenty individuals did not consider the pros and cons. When making their respective decisions, no one felt that they had been subjected to undue persuasion or force. Concerning the reasons for participating, a majority (n=35) supposed that participation would benefit themselves' as the primary reason. Some (n=11) considered the benefits for future patients and science. No differences concerning gender or age were discerned.
CONCLUSIONS: The results do not indicate that the informed consent procedure in general was inadequately performed. Rather, the answers provided and the subjects who withdrew indicate that participation was perceived as fully voluntary.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2001        PMID: 11817382

Source DB:  PubMed          Journal:  Med Law        ISSN: 0723-1393


  2 in total

Review 1.  Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis.

Authors:  Nguyen Thanh Tam; Nguyen Tien Huy; Le Thi Bich Thoa; Nguyen Phuoc Long; Nguyen Thi Huyen Trang; Kenji Hirayama; Juntra Karbwang
Journal:  Bull World Health Organ       Date:  2015-01-22       Impact factor: 9.408

2.  Motives for participating in a clinical research trial: a pilot study in Brazil.

Authors:  Solange A Nappo; Giovanna B Iafrate; Zila M Sanchez
Journal:  BMC Public Health       Date:  2013-01-10       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.